LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
Survival of patients with p53 mutations in the DNA-binding motifs... | Download Scientific Diagram
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers - ScienceDirect
Gastrointestinal Disorders | Free Full-Text | Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Cancers | Free Full-Text | TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines | PNAS
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome: Cell
Biomolecules | Free Full-Text | p53's Extended Reach: The Mutant p53 Secretome
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
Overall survival curves of patients with p53 mutation results. (A) p53... | Download Scientific Diagram
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors - Kim - 2023 - Cancer Medicine - Wiley Online Library
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer - Frontiers
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
Mutations in TP53 and other heterogeneous genes help to distinguish metastases from new primary malignancies | medRxiv
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Prognostic value of TP53 mutation location in breast cancer | CMAR
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics
